Johnson & Johnson’s (NYSE: JNJ) stock price can continue to advance because its strategy to reinvigorate growth and widen margins is working. The plan centers on divesting underperforming healthcare businesses to focus on higher-margin, more potent growth markets.
Among the details emerging from the Q3 release is the intention to spin off the orthopedics unit as a stand-alone business, a move that should enable further improvement in organic growth and earnings quality.
